ZYN and IQOS Scale Up: Is Philip Morris Leading the Industry Reset?

Core Insights - Philip Morris International Inc. (PM) is accelerating its transition from traditional tobacco to reduced-risk products, with smoke-free products accounting for 44% of total gross profit in Q1 2025, indicating significant progress towards becoming substantially smoke-free [1][8] Group 1: Product Performance - IQOS, PM's heat-not-burn device, achieved 9.4% growth in HTU-adjusted IMS, driven by strong performances in Japan and Europe [2] - ZYN, the oral nicotine pouch acquired from Swedish Match, saw shipments increase by 53% year-over-year to 202 million cans, with PM raising its 2025 shipment forecast to 800-840 million cans [2][8] Group 2: Financial Metrics - Smoke-free organic revenues increased by 20.4%, while gross profit rose by 33.1%, resulting in a gross margin exceeding 70%, significantly higher than combustible products [3][8] - PM's shares have increased by 52.3% year-to-date, outperforming the industry growth of 37% [7] Group 3: Competitive Landscape - Altria is expanding its smoke-free portfolio, with on! nicotine pouch shipments rising 18% year-over-year, contributing to $654 million in net revenues for its Oral Tobacco segment [5] - British American Tobacco aims for 50 million users of smoke-free products by 2030 and plans to derive 50% of revenues from this segment by 2035, with its New Category segment growing by 2.5% in 2024 [6] Group 4: Future Outlook - PM is well-positioned for future growth with strategic manufacturing investments in the U.S. and a multi-category strategy that includes e-vapor products [4] - The Zacks Consensus Estimate for PM's 2025 earnings suggests a year-over-year growth of 13.7%, with 2026 earnings expected to increase by 11.7% [12]